PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
Aurisco – 04/02/2025

Aurisco

Established in 1998, Aurisco is an innovative pharmaceutical company engaged in research, development, manufacturing and marketing of specialty APIs, formulations as well as CRDMO service. With 6 R&D centers and opening its 4th cGMP manufacturing site, the company has offices in USA, Portugal, China, India and Brazil. Aurisco has been deeply involved in the pharmaceutical industry for more than 26 years and commits itself to continuous technological innovation and sustainability. Having passed 5 cGMP inspections in 2023 (USFDA/EUGMP/PMDA/NMPA/KFDA), Aurisco Pharmaceutical is expanding with new workshops for peptides (Semaglutide, Tirzepatide) and Oligonucleotides (New oligoprocess flexfactory for ASOs and siRNAs) and a new manufacturing site in 2025, growing its toolbox of technologies, small molecule API offer and unbeatable CRDMO services for oligonucleotides and peptides. Today, the company plays a leading role in China and global markets in the field of complex synthesis, synthetic biology, photochemistry and continuous flow chemistry. Aurisco is Ecovadis Gold ranked and joined the SBTi with a target of becoming carbon neutral by 2027, reaching zero emissions by 2030, being a reliable long-term partner of the well-known pharmaceutical companies worldwide. Our focus on customer service, mature quality system, regulatory experience, growing production capacity and global sales network enables the company to provide high-quality products and efficient service to our customers around the world.

Commercial APIs API Name DMFDrug Mater File
Abiraterone AcetateEU,US,CANADA,CHINA,JAPAN, BRAZIL 
ApalutamideUS, CHINA
Bempedoic AcidEU, US, CHINA
Betamethasone ValerateEU(CEP), CANADA
BrivaracetamEU, US, CANADA, CHINA
Elagolix EU, US  
EnzalutamideEU, US, CHINA
Eplerenone EU(CEP), US, CANADA, JAPAN
Finerenone US, EU
DydrogesteroneEU(CEP), US, CHINA
Fluticasone PropionateEU(CEP), US, CHINA
Fluticasone FuroateEU(CEP), US, CHINA
Mometasone FuroateEU(CEP), US
Nusinersen (ASO, Oligonucleotides)DMF Ready
Pregabalin EU(CEP), US, CANADA, CHINA 
Relugolix US
SemaglutideUS
TDF (Tenofovir Disoproxil Fumarate)EU, US, CHINA
TAF (Tenofovir Alafenamide Hemifumarate)EU, US, CHINA
TMF(Tenofovir Alafenamide Monofumarate)EU, US, CHINA
Vibegron US
Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40